Melanoma Trial, Recruiting (NCT03702309)

Melanoma Trial, Recruiting NCT03702309 Sponsor: University Health Network, Toronto Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT03702309 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a solid tumor or a blood cancer, confirmed by a tissue sample (biopsy), OR you have been identified as being at high risk of developing cancer (for example, because you carry a gene linked to cancer, or because of your hormone levels or family history of cancer).
You are 18 years old or older.
You are willing and able to sign and date the consent form for this specific study (called the LIBERATE study).
If you are also joining a separate related research study at the same time, you must meet the eligibility requirements for that other study as well.

Who may not be able to join:

There are no specific reasons listed that would automatically prevent someone from joining this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lillian Siu, MD, Princess Margaret Cancer Centre

Phone: 416-946-4501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03702309

Sponsor: University Health Network, Toronto

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: 416-946-4501

More information: https://clinicaltrials.gov/study/NCT03702309

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a solid tumor or a blood cancer, confirmed by a tissue sample (biopsy), OR you have been identified as being at high risk of developing cancer (for example, because you carry a gene linked to cancer, or because of your hormone levels or family history of cancer).
You are 18 years old or older.
You are willing and able to sign and date the consent form for this specific study (called the LIBERATE study).
If you are also joining a separate related research study at the same time, you must meet the eligibility requirements for that other study as well.

Who may not be able to join:

There are no specific reasons listed that would automatically prevent someone from joining this trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Health Network, Toronto

Registry

ClinicalTrials.gov

Start date

3 August 2017

Est. completion

6 July 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Collection and annotation of biospecimens

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov